BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 28497177)

  • 21. Systematic searching and selection of health state utility values from the literature.
    Papaioannou D; Brazier J; Paisley S
    Value Health; 2013 Jun; 16(4):686-95. PubMed ID: 23796303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health State Utility Values in Schizophrenia: A Systematic Review and Meta-Analysis.
    Aceituno D; Pennington M; Iruretagoyena B; Prina AM; McCrone P
    Value Health; 2020 Sep; 23(9):1256-1267. PubMed ID: 32940244
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of health state utility values for acute myeloid leukemia.
    Forsythe A; Brandt PS; Dolph M; Patel S; Rabe APJ; Tremblay G
    Clinicoecon Outcomes Res; 2018; 10():83-92. PubMed ID: 29416365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing EQ-5D scores for comorbid health conditions estimated using 5 different methods.
    Ara R; Brazier J
    Med Care; 2012 May; 50(5):452-9. PubMed ID: 22002647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of the predictive accuracy of health-state utility values based on the Lloyd model for metastatic or recurrent breast cancer in Japan.
    Iwatani T; Inoue E; Tsugawa K
    BMJ Open; 2021 Dec; 11(12):e046273. PubMed ID: 34853098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elicitation of informed general population health state utility values: a review of the literature.
    McTaggart-Cowan H
    Value Health; 2011 Dec; 14(8):1153-7. PubMed ID: 22152187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Populating an economic model with health state utility values: moving toward better practice.
    Ara R; Brazier JE
    Value Health; 2010 Aug; 13(5):509-18. PubMed ID: 20230546
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health State Utility Values of Type 2 Diabetes Mellitus and Related Complications: A Systematic Review and Meta-Analysis.
    Redenz G; Ibaceta MC; Aceituno D; Balmaceda C; Espinoza MA
    Value Health Reg Issues; 2023 Mar; 34():14-22. PubMed ID: 36371899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic Review and Meta-Analysis of Community- and Choice-Based Health State Utility Values for Lung Cancer.
    Blom EF; Haaf KT; de Koning HJ
    Pharmacoeconomics; 2020 Nov; 38(11):1187-1200. PubMed ID: 32754857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quality Appraisal in Systematic Literature Reviews of Studies Eliciting Health State Utility Values: Conceptual Considerations.
    Muchadeyi MT; Hernandez-Villafuerte K; Di Tanna GL; Eckford RD; Feng Y; Meregaglia M; Peasgood T; Petrou S; Ubels J; Schlander M
    Pharmacoeconomics; 2024 Jul; 42(7):767-782. PubMed ID: 38551803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is Meta-Analysis for Utility Values Appropriate Given the Potential Impact Different Elicitation Methods Have on Values?
    Peasgood T; Brazier J
    Pharmacoeconomics; 2015 Nov; 33(11):1101-5. PubMed ID: 26133293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A systematic review of health state utility values in Thai cancer patients.
    Kangwanrattanakul K
    Expert Rev Pharmacoecon Outcomes Res; 2022 Dec; 22(8):1171-1186. PubMed ID: 36084926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The changing face of the cost-utility literature, 1990-2012.
    Neumann PJ; Thorat T; Shi J; Saret CJ; Cohen JT
    Value Health; 2015 Mar; 18(2):271-7. PubMed ID: 25773562
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of Evidence Sources for Health-Related Quality of Life in Cost-Utility Analysis of Pharmaceuticals in Japan.
    Azuma MK; Ikeda S
    Value Health Reg Issues; 2014 May; 3():190-196. PubMed ID: 29702927
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in Health State Utility Values in Japanese Patients with End-Stage Breast Cancer.
    Iwatani T; Noto S; Tsugawa K
    Curr Oncol; 2021 Oct; 28(5):4203-4212. PubMed ID: 34677274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Systematic Review of Health State Utility Values in the Plastic Surgery Literature.
    Christopher AN; Morris MP; Patel V; Klifto K; Fischer JP
    Plast Reconstr Surg Glob Open; 2021 Nov; 9(11):e3944. PubMed ID: 34849317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An off-the-shelf help list: a comprehensive catalog of preference scores from published cost-utility analyses.
    Bell CM; Chapman RH; Stone PW; Sandberg EA; Neumann PJ
    Med Decis Making; 2001; 21(4):288-94. PubMed ID: 11475385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Health state utility values by cancer stage: a systematic literature review.
    Pourrahmat MM; Kim A; Kansal AR; Hux M; Pushkarna D; Fazeli MS; Chung KC
    Eur J Health Econ; 2021 Nov; 22(8):1275-1288. PubMed ID: 34125315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incorporating Prior Beliefs Into Meta-Analyses of Health-State Utility Values Using the Bayesian Power Prior.
    Hatswell AJ
    Value Health; 2023 Sep; 26(9):1389-1397. PubMed ID: 37187235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in the Selection of Health State Utility Values by Sponsorship in Published Cost-Effectiveness Analyses.
    Hendrix N; Kim DD; Patel KS; Devine B
    Med Decis Making; 2021 Apr; 41(3):366-372. PubMed ID: 33451278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.